Ludwig Scientists to Present at AACR Meeting

Researchers will share expertise and discoveries at annual cancer conference

Apr. 17, 2026 at 2:26am

Got story updates? Submit your updates here. ›

A highly textured, abstract painting in soft pastel colors featuring sweeping geometric shapes, concentric circles, and precise botanical spirals, conceptually representing the complex and interconnected nature of cancer research.Ludwig Cancer Research's participation in the AACR Annual Meeting underscores the organization's commitment to advancing cancer research through innovative scientific exploration.San Diego Today

Ludwig Cancer Research has announced that several of its affiliated scientists will present their research at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2026, which will take place both online and in person in San Diego, California from April 17th to 27th.

Why it matters

The AACR Annual Meeting is one of the premier cancer research conferences, providing a platform for scientists to share their latest findings and advancements in the field. Ludwig's participation underscores the organization's commitment to driving progress in cancer research and treatment.

The details

Ludwig researchers will deliver talks and present posters showcasing their work at the AACR meeting. The full scope of Ludwig's participation, including a list of presentations and posters, has been released by the organization.

  • The AACR Annual Meeting 2026 will be held from April 17th to 27th.
  • Ludwig's affiliated scientists will present their research at the conference.

The players

Ludwig Cancer Research

A leading cancer research organization that supports the work of scientists and clinicians around the world.

American Association for Cancer Research (AACR)

A professional organization dedicated to advancing cancer research and the prevention and treatment of cancer.

Got photos? Submit your photos here. ›

The takeaway

The participation of Ludwig researchers at the AACR Annual Meeting underscores the organization's commitment to driving progress in cancer research and treatment, and its scientists' contributions to advancing the field.